For the quarter ending 2025-09-27, USNA had -$5,973K decrease in cash & cash equivalents over the period. -$5,159K in free cash flow.
| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net (loss) earnings | -6,662 | 19,734 |
| Depreciation and amortization | 7,919 | 16,082 |
| Right-of-use asset reduction | 1,648 | 3,767 |
| Loss on sale of property and equipment | -95 | -29 |
| Equity-based compensation expense | 3,576 | 6,502 |
| Deferred income taxes | 2,023 | -6,485 |
| Inventory write-down | 370 | 2,045 |
| Inventories | 8,155 | 12,988 |
| Prepaid expenses and other assets | -261 | 460 |
| Accounts payable | -1,682 | 5,813 |
| Other liabilities | -1,354 | -6,339 |
| Net cash provided by (used in) operating activities | -1,961 | 27,700 |
| Proceeds from the settlement of net investment hedges | 0 | 0 |
| Payments for net investment hedge | 0 | 1,072 |
| Proceeds from acquisition working capital adjustment | 0 | 865 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Purchases of property and equipment | 3,198 | 7,830 |
| Net cash provided by (used in) investing activities | -3,198 | -8,037 |
| Repurchase of common stock | 0 | 27,507 |
| Borrowings on line of credit | 0 | 1,600 |
| Payments on line of credit | 0 | 24,600 |
| Payments related to tax withholding for net-share settled equity awards | 100 | 2,191 |
| Distributions to redeemable noncontrolling interest | 879 | 379 |
| Net cash provided by (used in) financing activities | -979 | -53,077 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 165 | 3,032 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -5,973 | -30,382 |
| Cash and cash equivalents at beginning of period | 184,508 | - |
| Cash and cash equivalents at end of period | 148,153 | - |
USANA HEALTH SCIENCES INC (USNA)
USANA HEALTH SCIENCES INC (USNA)